DOSSIER MANAGEMENT
Index
 1- Dossier
 2- DossiersandRegulatory Affairs
 3- BenefitsandApplications
 4- EffectiveDossierManagement
 5- Aspectsof DossierManagement
 A) Planning
 B) Formatting and Compilation
 C) Review
 6- KeySoftwareSkills
DOSSIER
It s a complete set of document.
•A collection of papers giving detailed information about
particular person or subject.
Dossier and Regulatory Affairs :
Dossier helps ,
•To create, assemble, update and publish a composite
document(s) from various individual document sources
and formats.
•A compound document is resulting from a dynamic
merge and assembly of elementary documents
monitored by a structuring and publishing agent (the
Dossier module).
•Elementary documents might be of heterogeneous
types and formats. They should be managed as a whole.
For instance, a training manual can be made up of Word
documents, Powerpoint presentations, Excel
spreadsheets . It is published and made available to all
users as a single document.
Dossier and Regulatory Affairs :
• All documents are managed as a single, consistent,
structured and unified document. No more time wasted
on assembling and maintaining a constantly moving
document means immediate return on investment.
•Each document or sub dossier follows its own lifecycle.
Individual changes update in real time the whole dossier.
•Dossier allows various combinations of the same
content in order to adapt to different contexts or targets:
FDA approval, other regulatory approval,
suppliers/customers needs, auditing purposes, etc.
APPLICATIONS:
• For registration of Pharmaceutical
Products.
•In Local market.
•In International market.
For renewal of registration of
Pharmaceutical Products.
•The registration dossier for
medicines is an important document
which is submitted for review to
regulatory agencies by
pharmaceutical companies for
approval to market their medicines.
• Utmost care should be taken during
its compilation and filing as it plays
a direct role in earliest possible
availability of medicines in the
market which in turn translates into
business for the company.
Regulatory affairs professionals need
to ensure the safety, quality and
efficacy of the medicines for which
they are filing registration dossier.
Note : The dossiers could be anything
among DMF, ASMF, ANDA, NDA or
MAA.
(DMF = DRUG MASTER FILE)
(ASMF = ACTIVE SUBSTANCE MASTER FILE )
(ANDA = ABRRIVIATED NEW DRUG APPLICATION )
(NDA = NEW DRUG APPLICATION )
(MAA = MARKETING AUTHORISATION
APPLICATION )
Deadline-It is important to know the
deadline for filing the dossier and action
plan should be prepared so as to meet the
deadline.
2 - Understanding the registration
requirements of respective agencies-
Although most of the regulatory agencies
accept the CTD format for registration
dossier, the requirements for
approving marketing applications may
vary for individual agencies.
For example- USFDA requires Batch
Manufacturing Records to be provided,
while it is not necessary for approval by
European regulatory agencies. Hence it is
necessary to completely read and
understand the guidance document of each
regulatory agency before going ahead with
filing registration dossier with them.
3- Requirements Listing-
Listing down all the requirements for
preparing the registration dossier. Listing
down all the requirements for preparation
of all the modules and their respective
sections is an important aspect.
4- Sending the requirements list to
respective departments-
Preparing an individual requirement list and
sending them to each respective department. For
example I need to have all the information
regarding the general properties, synthetic
scheme, manufacturing process development of
drug from R & D department and finalized
specification & test procedures, Batch
manufacturing sheets from Quality assurance
department.
Format-
As per the ICH's M4 guideline the following are
recommended-
1- The display of information should be
unambiguous and transparent.
2- Text and tables should be prepared using margins
that allow the document to be printed on both A4
and 8.5 x 11” paper (For Europe and Japan regions A4
paper is recommended and 8.5 x 11” paper for USA).
3- Times New Roman, 12-point font is recommended
for narrative text.
4- The left-hand margin should be sufficiently large that
information is not obscured by the method of binding.
5- Font sizes for text and tables should be of a style and
size that are large enough to be easily legible, even after
photocopying.
6- Every page should be numbered, according to the
granularity document.
5- Acronyms and abbreviations should be defined the
first time they are used in each module.
6- References should be cited in accordance with the
current edition of the Uniform Requirements for
Manuscripts Submitted to Biomedical Journals,
International Committee of Medical Journal Editors
(ICMJE).
7- All pages of a document should include a unique
header or footer that briefly identifies its subject matter.
The following compilation aspects are important-
•The information should be specific, clear, precise and
accurate.
•Typographical and grammatical errors should be avoided.
•The information should be arranged in a sequential order in
computer. Each module could have a separate folder and in
turn each section of a module could have a separate folder.
•This kind of orderly arrangement will help in easy access of
information and help in taking printouts of finalized copy
conveniently.
•The line spacing should be preferably single.
• All the documents received from other departments should
be cross-checked so as to ensure that they are free from errors.
•Ensuring the specifications & test procedures are designed in
accordance with ICH guidelines .
•After the finalized soft copy is ready, printouts should be
taken using a good quality printer and arranged sequentially
in a module and section wise manner.
•It is important to re check the information in the
dossier before filing it with regulatory agencies.
•It is also important that a dossier meant to be filed
with a regulatory agency should be cross verified by a
person other than the one who has complied the
dossier.
•It is very useful to have a check list so as to ensure that
all the required information is present in the dossier
before submission to regulatory agency.
Key software skills for effective dossier
management-
Proficiency in MS office .
Proficiency in Adobe Acrobat tools.
Dossier Management and Regulatory Affairs.

Dossier Management and Regulatory Affairs.

  • 1.
  • 2.
    Index  1- Dossier 2- DossiersandRegulatory Affairs  3- BenefitsandApplications  4- EffectiveDossierManagement  5- Aspectsof DossierManagement  A) Planning  B) Formatting and Compilation  C) Review  6- KeySoftwareSkills
  • 4.
    DOSSIER It s acomplete set of document. •A collection of papers giving detailed information about particular person or subject. Dossier and Regulatory Affairs : Dossier helps , •To create, assemble, update and publish a composite document(s) from various individual document sources and formats. •A compound document is resulting from a dynamic merge and assembly of elementary documents monitored by a structuring and publishing agent (the Dossier module). •Elementary documents might be of heterogeneous types and formats. They should be managed as a whole. For instance, a training manual can be made up of Word documents, Powerpoint presentations, Excel spreadsheets . It is published and made available to all users as a single document.
  • 5.
    Dossier and RegulatoryAffairs : • All documents are managed as a single, consistent, structured and unified document. No more time wasted on assembling and maintaining a constantly moving document means immediate return on investment. •Each document or sub dossier follows its own lifecycle. Individual changes update in real time the whole dossier. •Dossier allows various combinations of the same content in order to adapt to different contexts or targets: FDA approval, other regulatory approval, suppliers/customers needs, auditing purposes, etc.
  • 8.
    APPLICATIONS: • For registrationof Pharmaceutical Products. •In Local market. •In International market. For renewal of registration of Pharmaceutical Products.
  • 9.
    •The registration dossierfor medicines is an important document which is submitted for review to regulatory agencies by pharmaceutical companies for approval to market their medicines. • Utmost care should be taken during its compilation and filing as it plays a direct role in earliest possible availability of medicines in the market which in turn translates into business for the company.
  • 10.
    Regulatory affairs professionalsneed to ensure the safety, quality and efficacy of the medicines for which they are filing registration dossier. Note : The dossiers could be anything among DMF, ASMF, ANDA, NDA or MAA. (DMF = DRUG MASTER FILE) (ASMF = ACTIVE SUBSTANCE MASTER FILE ) (ANDA = ABRRIVIATED NEW DRUG APPLICATION ) (NDA = NEW DRUG APPLICATION ) (MAA = MARKETING AUTHORISATION APPLICATION )
  • 12.
    Deadline-It is importantto know the deadline for filing the dossier and action plan should be prepared so as to meet the deadline.
  • 13.
    2 - Understandingthe registration requirements of respective agencies- Although most of the regulatory agencies accept the CTD format for registration dossier, the requirements for approving marketing applications may vary for individual agencies.
  • 14.
    For example- USFDArequires Batch Manufacturing Records to be provided, while it is not necessary for approval by European regulatory agencies. Hence it is necessary to completely read and understand the guidance document of each regulatory agency before going ahead with filing registration dossier with them.
  • 15.
    3- Requirements Listing- Listingdown all the requirements for preparing the registration dossier. Listing down all the requirements for preparation of all the modules and their respective sections is an important aspect.
  • 16.
    4- Sending therequirements list to respective departments- Preparing an individual requirement list and sending them to each respective department. For example I need to have all the information regarding the general properties, synthetic scheme, manufacturing process development of drug from R & D department and finalized specification & test procedures, Batch manufacturing sheets from Quality assurance department.
  • 17.
    Format- As per theICH's M4 guideline the following are recommended- 1- The display of information should be unambiguous and transparent. 2- Text and tables should be prepared using margins that allow the document to be printed on both A4 and 8.5 x 11” paper (For Europe and Japan regions A4 paper is recommended and 8.5 x 11” paper for USA). 3- Times New Roman, 12-point font is recommended for narrative text.
  • 18.
    4- The left-handmargin should be sufficiently large that information is not obscured by the method of binding. 5- Font sizes for text and tables should be of a style and size that are large enough to be easily legible, even after photocopying. 6- Every page should be numbered, according to the granularity document. 5- Acronyms and abbreviations should be defined the first time they are used in each module.
  • 19.
    6- References shouldbe cited in accordance with the current edition of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, International Committee of Medical Journal Editors (ICMJE). 7- All pages of a document should include a unique header or footer that briefly identifies its subject matter.
  • 20.
    The following compilationaspects are important- •The information should be specific, clear, precise and accurate. •Typographical and grammatical errors should be avoided. •The information should be arranged in a sequential order in computer. Each module could have a separate folder and in turn each section of a module could have a separate folder. •This kind of orderly arrangement will help in easy access of information and help in taking printouts of finalized copy conveniently.
  • 21.
    •The line spacingshould be preferably single. • All the documents received from other departments should be cross-checked so as to ensure that they are free from errors. •Ensuring the specifications & test procedures are designed in accordance with ICH guidelines . •After the finalized soft copy is ready, printouts should be taken using a good quality printer and arranged sequentially in a module and section wise manner.
  • 22.
    •It is importantto re check the information in the dossier before filing it with regulatory agencies. •It is also important that a dossier meant to be filed with a regulatory agency should be cross verified by a person other than the one who has complied the dossier. •It is very useful to have a check list so as to ensure that all the required information is present in the dossier before submission to regulatory agency.
  • 23.
    Key software skillsfor effective dossier management- Proficiency in MS office . Proficiency in Adobe Acrobat tools.